NASDAQ:SVA - Nasdaq - AGP8696W1045 - Common Stock - Currency: USD
NASDAQ:SVA (2/22/2019, 8:00:00 PM)
6.47
-0.02 (-0.31%)
The current stock price of SVA is 6.47 USD. In the past month the price increased by 0.15%. In the past year, price decreased by -21%.
Sonovac Biotech Ltd. specializes in the research, development, commercialization, and sales of human vaccines for infectious illnesses such as hepatitis A and hepatitis B, influenza, `SARS`, and avian flu. Sinovac is one of the leading emerging biotechnology companies in China.
SINOVAC BIOTECH LTD
39 SHANGDI XI ROAD HAIDIAN DISTRICT
BEIJING F4 102200
CEO: Weidong Yin
Phone: 86-10-5693-1800
The current stock price of SVA is 6.47 USD. The price decreased by -0.31% in the last trading session.
The exchange symbol of SINOVAC BIOTECH LTD is SVA and it is listed on the Nasdaq exchange.
SVA stock is listed on the Nasdaq exchange.
SINOVAC BIOTECH LTD (SVA) has a market capitalization of 368.91M USD. This makes SVA a Small Cap stock.
SINOVAC BIOTECH LTD (SVA) has a support level at 6.46 and a resistance level at 6.5. Check the full technical report for a detailed analysis of SVA support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
SVA does not pay a dividend.
SINOVAC BIOTECH LTD (SVA) will report earnings on 2022-04-21, after the market close.
The PE ratio for SINOVAC BIOTECH LTD (SVA) is 14.7. This is based on the reported non-GAAP earnings per share of 0.44 and the current share price of 6.47 USD. Check the full fundamental report for a full analysis of the valuation metrics for SVA.
The outstanding short interest for SINOVAC BIOTECH LTD (SVA) is 0.2% of its float. Check the ownership tab for more information on the SVA short interest.
ChartMill assigns a technical rating of 1 / 10 to SVA. When comparing the yearly performance of all stocks, SVA is a bad performer in the overall market: 85.87% of all stocks are doing better.
ChartMill assigns a fundamental rating of 4 / 10 to SVA. SVA has only an average score on both its financial health and profitability.
Over the last trailing twelve months SVA reported a non-GAAP Earnings per Share(EPS) of 0.44. The EPS increased by 1566.67% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 14.8% | ||
ROA | 8.39% | ||
ROE | 13.09% | ||
Debt/Equity | 0.06 |